The National Agency for Food and Drug Administration and Control (NAFDAC) has warned Nigerians to be wary of counterfeit cancer treatment drugs, Phesgo, in circulation.

The National Agency for Food and Drugs Administration and Control has alerted healthcare providers and the public about a suspected counterfeit batch of Phesgo 600mg/600mg/10ml injection ...

Roche's strategic acquisition of Poseida Pharmaceuticals positions them as a leader in the allogeneic cell therapy market. Learn more on RHHBY stock here.

“The Marketing Authorization Holder (MAH) Roche received a complaint from a doctor at Lagos University Teaching Hospital (LUTH-NSIA) reporting a suspected counterfeit Phesgo® 600mg ...

The National Agency for Food and Drug Administration and Control, NAFDAC, has alerted Nigerians, including healthcare providers, about a counterfeit cancer treatment drug, Phesgo 600mg/600mg/10ml ...

Analyst Daina Graybosch of Leerink Partners maintained a Buy rating on Merck & Company (MRK – Research Report), reducing the price target ...

Shares of Halozyme Therapeutics, Inc. HALO were up 5% on Jan. 8 after the company raised its guidance for 2025. The stock gained another 1.8% in after-hours trading. HALO also maintained its full-year ...

In the last few months, some unscrupulous elements have intensified their illegal operations across the country, freely circulating fake and substandard drugs as well as unwholesome food and drinks.

and by the continued strong growth of Darzalex SC and Phesgo. Three additional products, Ocrevus Zunovo, Tecentriq Hybreza and Opdivo Qvantig, which are in the early stages of commercialization ...